PUBLISHER: Grand View Research | PRODUCT CODE: 1405821
PUBLISHER: Grand View Research | PRODUCT CODE: 1405821
The global muscle stimulator market size is anticipated to reach USD 997.3 million by 2030, registering a CAGR of 3.5% over the forecast period, according to a new report by Grand View Research, Inc. The growing prevalence of musculoskeletal disorders and increasing demand for pain management therapies are the key factors driving the growth over the forecast period. Moreover, growing purchasing power, increasing healthcare expenditure, and technological innovations in medical devices are also driving the market growth.
Based on product type, Transcutaneous Electrical Nerve Stimulation (TENS) dominated the global market in 2019. Increasing demand for portable stimulation devices that can be operated at home and rising geriatric population that is prone to develop musculoskeletal disorders are the major factors driving the market growth. On the other hand, Neuromuscular Electrical Stimulation (NES) is estimated to be the fastest-growing segment during the forecast period owing to increasing cases of strokes and spinal cord injuries.
Based on modality, the market is segmented into portable, handheld, and tabletop. Portable stimulator dominated the muscle stimulator space in 2019, owing to the ease of carrying them while traveling and higher purchasing power in the hands of consumers. The segment is also anticipated to grow at the fastest rate of 4.2% during the forecast period. Key players launching innovative portable muscle stimulator devices to sustain market competition is also a major factor driving the segment growth.
Based on applications, the muscle stimulator market is segmented into pain management, neurological disorders, musculoskeletal disorders, and others. The pain management segment dominated the market with a share of 54.5% in 2019 and is anticipated to be the fastest growing segment during the forecast period. Increasing cases of chronic and acute pain and the need for effective pain management therapies among cancer patients are the major factors driving the growth over the forecast period.